Anthem Biosciences Limited (NSE:ANTHEM)
654.45
-7.55 (-1.14%)
At close: Dec 5, 2025
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 367.55 billion as of December 5, 2025.
Market Cap
367.55B
Enterprise Value
358.33B
Revenue
20.77B
Ranking
n/a
PE Ratio
71.03
Stock Price
654.45
Market Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has decreased from 410.17B to 367.55B, a decrease of -10.39%. That is a compound annual growth rate of -25.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 367.55B | -10.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,362.71B |
| Divi's Laboratories | 1,717.32B |
| Cipla | 1,228.62B |
| Apollo Hospitals Enterprise | 1,035.39B |
| Zydus Lifesciences | 941.58B |
| Mankind Pharma | 910.67B |
| Aurobindo Pharma | 710.38B |
| Alkem Laboratories | 676.62B |